Viewing nowAnfleat Sustained Release Tablet 300 mg (Sarpogrelate Hydrochloride)
Sarpogrelate Hydrochloride 200mg
Tablet · Prescription medication
Biphozon Pharmaceutical Co., Ltd.

MFDS item code 201903477 · Approved 2019.05.28 · Insurance code 658204320
Improvement of ischemic symptoms due to chronic arterial occlusive disease (ulcers, pain, etc.)
This medication is used to improve ischemic symptoms such as ulcers, pain, and coldness that occur due to chronic arterial occlusive disease. It is particularly helpful in alleviating symptoms associated with conditions such as Buerger's disease, occlusive arterial sclerosis, and diabetic peripheral vascular disease, thus aiding blood flow improvement. Ultimately, this drug is effectively used to alleviate ischemic symptoms related to chronic arterial occlusive disease.
Administer Sarpogrelate Hydrochloride sustained release tablets 300 mg orally once daily after meals. This medication should be swallowed whole and not chewed or crushed.
This medication should not be administered to patients with bleeding. There is a risk that bleeding may worsen in patients with bleeding disorders, such as hemophilia or gastrointestinal ulcers. Women who are pregnant or may become pregnant should avoid taking this medication. It may be harmful to the fetus, and breastfeeding women are also advised to avoid this medication while nursing. Patients who are menstruating or have a tendency to bleed should use this medication cautiously due to the increased risk of bleeding. If taken together with anticoagulants or platelet aggregation inhibitors, the risk of bleeding may increase, so it is essential to consult with healthcare professionals. Patients with severe renal impairment or the elderly should be cautious when using this medication and should regularly monitor their condition through blood tests. While taking this medication, various adverse reactions such as urticaria, dyspepsia, diarrhea, headache, and cough may occur, so if any symptoms arise, they should be reported to a healthcare professional immediately. Serious adverse reactions such as gastrointestinal bleeding, intracerebral hemorrhage, liver dysfunction, and blood disorders have been reported, so if such symptoms are suspected, the administration should be stopped immediately and appropriate treatment should be sought. This medication is not recommended for children as safety has not been established. Store this medication out of the reach of children, and avoid transferring it to another container as it may adversely affect product quality.
Urticaria, bleeding tendency (gastrointestinal bleeding, intracranial hemorrhage, subcutaneous bleeding), agranulocytosis, anemia, thrombocytopenia, leukopenia, acute hepatitis, liver disorders, jaundice, thrombocytopenia, chest discomfort, dyspnea, severe rash with high fever, blisters, skin peeling, pain in oral/ocular mucosa, severe swelling (edema), severe edema or urinary abnormalities, sudden and severe headache, thunderclap headache, seizures, consciousness confusion, visual disturbances.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. It is advisable to maintain a storage temperature between 1 degree and 30 degrees Celsius at room temperature. This will help preserve the medication's effectiveness for a longer period.
White oblong film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSarpogrelate Hydrochloride 200mg
Tablet · Prescription medication
Biphozon Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Yuhan Corporation

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Korea United Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
(Co., Ltd.) Pharmgen Science

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Dongkook Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Haewon Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Allico Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.